GWM
BBIO icon

GK Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

GK Wealth Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.5K Buy
+114
New +$8.88K ﹤0.01% 956

Other funds holding BBIO

CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

GK Wealth Management's BBIO Position: Q3 2026 in Review

GK Wealth Management opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 114 shares worth $7.5K. The stake represents ﹤0.01% of the portfolio and ranks #956 among its holdings.

12 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • GK Wealth Management held 114 shares of BridgeBio Pharma worth $7.5K as of Q3 2026.
  • BridgeBio Pharma was a new GK Wealth Management position in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of GK Wealth Management's portfolio in Q3 2026, its #956 holding.
  • 12 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.